Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Esbjerg
Clinical trial register · Denmark

Clinical Trials in Esbjerg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Odense 81 Copenhagen 16 Aalborg 15 Aarhus 13 Svendborg 12
Narrow the registerReset
Recruitment status
Phase
Site location
Odense81 Copenhagen16 Aalborg15 Aarhus13 Svendborg12
All 25 locations
Target enrolment
to

Trials with a site in Esbjerg

9 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Bracing After Ankle Fracture
NCT07163091Ankle Fracture, Rehabilitation, Recovery
Odense University Hospital
Not applicable
1,400
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre
2026-04-23
Not yet open
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Odense University Hospital
Phase 4
166
Aalborg, Esbjerg, Hvidovre, Nyborg, Odense, Vejle
2025-09-01
Recruiting
Prehabilitation to Patients With Prostate Cancer
NCT07162987Prostate Cancer (Diagnosis)
Odense University Hospital
Not applicable
20
Esbjerg, Nyborg, Vejle
2025-08-04
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949Metastatic Breast Cancer, Response Monitoring
Odense University Hospital
Not applicable
420
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Sønderborg, Vejle
2025-04-02
Recruiting
Type 1 Diabetes and Diabetes Distress
NCT06936280Diabetes Distress, Diabetes Mellitus Type 1
Odense University Hospital
Not applicable
100
Esbjerg, Odense, Sønderborg
2025-04-01
Recruiting
Odense University Hospital
Phase 4
1,400
Aalborg, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre, Odense
2025-02-21
Active, closed
Odense University Hospital
Phase 2
36
Esbjerg, Odense C
2024-11-04
Recruiting
The Safe Fast Track Study
NCT06219486Emergency Department, Non-specific Complaints
Odense University Hospital
Not applicable
1,538
Esbjerg, Odense
2024-01-22
Recruiting
Early Initiated Vasopressor Therapy in the Emergency Department
NCT05931601Shock, Shock, Septic, Hypotension, Hypotension and Shock
Odense University Hospital
Phase 3
320
Copenhagen, Esbjerg, Herning, Køge, Odense
2023-12-08
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/esbjerg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Esbjerg that also match the filters currently applied.

How many clinical trials are recruiting in Esbjerg?

7 of the 9 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Esbjerg), 9 studies
PhaseStudiesRecruitingShare
Not applicable5555.6%
Phase 42122.2%
Phase 21011.1%
Phase 31111.1%

Most active sponsors

Lead sponsors with the most studies (Esbjerg)
Lead sponsorStudiesRecruiting
Odense University Hospital97
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.